Dr. Michael (Mike) Perry is passionate about supporting innovative healthcare companies develop and commercialize products and technologies intended to address unmet medical needs in patients. He is inspired to invest in and recurrently assume leadership roles in companies employing cutting edge medical technologies including regenerative medicines such as cell, gene and tissue therapies.
Role
Mike is currently a Venture Partner of Bioscience Managers Pty Ltd and CEO of Avita Medical Ltd. He concurrently serves as Adjunct Professor at the Gates Center for Regenerative Medicine at the Anschutz Medical Campus of University of Colorado, Denver and he Chairs the External Advisory Board for Translational Medicine at the Houston Methodist Research Institute.
Experience
Mike has over 30 years of experience in the healthcare industry ranging from a variety of executive roles in top tier large pharma companies, to serving as CEO for multiple Biotech/Medtech companies, and operating for as a venture partner in a US-based healthcare VC fund with ~$1.5B under management.
Qualifications
He earned a BSc with honors in Physics from the University of Guelph, a Doctor of Veterinary Medicine and Surgery with honors from the Ontario Veterinary College, and a PhD with honors in Biomedical Pharmacology from the University of Guelph. He is also a graduate of the International Advanced Management Program at Harvard Business School.
Current board positions
Armata Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals
Avita Medical Ltd
Gamida Cell Ltd
Past board positions
American Xeno Inc.
Arriva Therapeutics
California Healthcare Institute
Genetic Therapy, Inc
Itamar Medical
Keck Graduate Institute
PharSight Corp.
SyStemix Inc.
Targeted Genetics
Xenotransplant, Inc.
